Bayard Design LLC is proud to announce our sponsorship of Medical Development Group Boston (MDG-Boston) for the 2019 and 2020 series of events.
Founder and Principal Matthew De Remer says “MDG is a great resource in the Boston area entrepreneur and medical device engineering communities. As far back as the Newton corner Bertucci’s days you could always find inspiration or advise at a meeting. We’re pleased to support its educational mission.”
The topic for the first meeting will be:
Sept 4 – Wednesday Current and Emerging Technologies in Point-of-Care Diagnostics
Rapid Diagnosis at Bedside or Remotely The Next Big Medical Game Changer What This Means for Clinicians,Patients, and Competitiveness in the Medical Device Market Mobile digital diagnostic technologies enable the advancement of digital biomarkers through continuous measurement of biological and pathogenic processes or pharmacological responses that translate to informative and actionable clinical insights.
Engineering advances lead to accelerated clinical adoption and winning business models
Daniel Sands, MD, MPH Beth Israel Deaconess Medical Center, Lahey Health Assistant Professor Harvard Medical School Unmet Clinical Needs and Market Adoption: Opportunities and Challenges Dr. Sands will address unmet clinical needs in care settings that require immediate data and situations where turnaround times for central laboratory results are insufficient to deliver quality care.
Anuj Dhingra, MBA Vice President, Product Lifecycle Management and Global Marketing, Siemens Healthineers POC Diagnostics Clinical Solutions Mr. Dhingra is responsible for effectively balancing the strategic, market, technical, and business aspects of all products within the Point of Care business unit. Andrea Paraboschi, PhD Program Manager, EmpaticaEpisode Detection and Caregiver Notification: Innovation in Patient Wearables Empatica has developed a medical-quality consumer wristband, called Embrace, that monitors stress signals to detect Generalized Tonic-Clonic (GTC) seizures, alert wearers and caregivers. Dr. Paraboschi oversees Empatica’s participation and the use of Empatica technology in support of large initiatives including clinical trials, global research projects, and federally funded research programs.
Qinxin (Chelsea) Pan, MS, PhD Director Health Advances, a Parexel Company Leveraging Digital Health to Transform Clinical Trials Dr. Pan is a leading authority on digital health and serves as Health Advances’ most senior project manager addressing innovation in digital health, devices, and biopharmaceuticals in the U.S., EU, and APAC. As part of the HIT/Digital Health team, she has a particular focus in Digital Biomarkers spanning routine care and clinical trials.
